We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Shutters Contract Manufacturer Over Adulterated Drugs
FDA Shutters Contract Manufacturer Over Adulterated Drugs
January 21, 2011
A federal court has ordered Deltex Pharmaceuticals, its president, Kabir Ahmed, and vice president, Mohidur Khan, to immediately cease all operations, pending full compliance with FDA requirements following repeated current good manufacturing practice (cGMP) violations.